Astorg Partners
Astorg cuts flagship fundraising target with EUR 4bn raised
French GP initially expected to raise around EUR 6.5bn for eighth flagship fund, Unquote previously reported
The Bolt-Ons Digest – 21 February 2023
Unquote’s selection of the latest add-ons with Investindustrial's CEME, Astorg's Fastmarkets, H&F's TeamSystem, and more
The Bolt-Ons Digest – 14 December 2022
Unquote’s selection of the latest add-ons, including CVC's Stark Group, Bridgepoint's Kereis, EQT's Open Systems, and more
Haul of large funds closings in Q1 2023 clouds new managers outlook – conference
Good news is drop in valuations could feed good vintages in the coming years, participants at SuperInvestor tell Unquote
The Bolt-Ons Digest – 17 October 2022
Unquote’s selection of the latest add-ons with Equistone's Ligentia, Bridgepoint's Infinigate, Ambienta’s Namirial and more
Astorg gears up for EUR 6.5bn close for Fund VIII next year
French sponsor seeing “good level” of re-ups; tapping retail investors and HNWI money
Astorg, Epiris to split Euromoney in two in GBP 1.6bn agreed offer
The deal will see Astorg carve out the Fastmarkets commodity pricing brand, with the remaining business controlled by Epiris funds
Deft deployment, creative exits drive PE agenda into H2 2022
Take-privates, bolt-on opportunities and demand for resilient healthcare and technology assets offer hope for challenging second half of the year
Astorg, Epiris could turn to private debt for Euromoney takeover
Suitors expected to consider bringing in direct lenders for proposed GBP 1.6bn buyout
Kester nets 8x on Avania exit to Astorg
Medical device CRO is Astorg's first healthcare deal from its EUR 1.3bn Mid-Cap fund
EcoVadis valued at over USD 1bn in Astorg, BeyondNetZero-led round
Deal brings total raised by sustainability rating group to USD 725m; CVC remains largest institutional shareholder
Astorg buys Open Health in SBO from Amulet
The medical communications company was Amulet's only asset outside of North America
Astorg adds new partner to Paris office
With addition of Jean Raby, Astorg will establish two new functions
Astorg beats sponsors to acquire CordenPharma
The sponsor competed with Advent International in the final round of an auction led by William Blair
Astorg closes Mid-Cap Fund on EUR 1.3bn
Fund will target EUR 150m-500m EV deals, expanding on Astorg’s current flagship strategy
Astorg promotes Le Baron and Veber to partner
Charles-Hubert Le Baron and Thibault Veber have worked at Astorg for a combined 16 years
Astorg Partners invests in Armor Iimak
Auction process for the packaging-printing specialist kicked off in early November 2021
Carlyle clinches AutoForm in SBO from Astorg
Permira, Onex, EQT, KKR and Hellman & Friedman, as well as industry players, were also tipped as potential bidders
AutoForm bidder pool narrows to include Carlyle, Francisco Partners
Sale of the business has tightened after attracting early interest from a raft of sponsors and trade players
AutoForm sees Permira join bidder pool ahead of NBOs next week
Carlyle, KKR, EQT, Hellman & Friedman and Francisco Partners were previously reported as potential bidders
Bregal kickstarts ATP sale process; Morgan Stanley advises
Tapes specialist is expected to generate EUR 45m in EBITDA from EUR 175m in sales this year
Astorg, Goldman Sachs to sell HRA Pharma for EUR 1.8bn
Astorg and Goldman Sachs acquired the French asset for EUR 300m-500m in 2016
Astorg to sell Flowbird to Searchlight
Astorg bought the urban transportation and parking service (then known as Parkeon) for EUR 450m in 2016
Astorg acquires surgery supplies manufacturer Demetra
Keensight merged medical technology businesses Tecres and Aap Biomaterials to form Demetra in 2016